In one paragraphArticle in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
David J ShirleyStructural Genomics Consortium and Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0009-0003-2475-7366 Ikeer Mancera-OrtizStructural Genomics Consortium and Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0009-0005-7877-8562 Peter J StogiosDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, M5G 1M1, Canada.ORCID 0000-0001-8663-1425 Nicole RobbinsDepartment of Molecular Genetics, University of Toronto, Toronto, ON, M5G 1M1, Canada.ORCID 0000-0003-2821-9269 Luke WhitesellDepartment of Molecular Genetics, University of Toronto, Toronto, ON, M5G 1M1, Canada.ORCID 0000-0001-6445-5766 David H DrewryStructural Genomics Consortium and Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0001-5973-5798 Timothy M WillsonStructural Genomics Consortium and Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0003-4181-8223 Funding
Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5MTargeting the casein kinase 1 (CK1)-like kinase Yck2 in fungal pathogenesisR01AI162789 · NIAID · UNIVERSITY OF TORONTO · PI LEAH Elizabeth Cowen, Timothy M Willson · 2022 to 2026
$3.1MElucidating the mechanism of action of novel ClpP activators in activation of the mitochondrial unfolded protein response.R01GM138520 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GRAVES, LEE M · 2020 to 2023
$1.3MRequest for a 500 MHz NMR console and nitrogen-cooled cryoprobeS10OD032476 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEE, ANDREW L · 2022 to 2022
$599kNCI NIH HHS P30 CA016086NIAID NIH HHS R01 AI162789NIGMS NIH HHS R01 GM138520NIH HHS S10 OD032476
6 · The paper itselfAbstract
Candida albicans is a growing global health threat, causing 1.5 million invasive infections and 1 million deaths annually. Yeast casein kinase 2 (Yck2) in
Indexed as
Antifungaldiarylpyrazolekinase inhibitor
Identifiers
PMID40672256
PMCPMC12265645
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390